This project proposes to develop the methodologies necessary to derive a functioning transplantable humanized lung from normal or disease-specific induced pluripotent stem (iPS) cells. Successful transplantation of this bioengineered lung would imply that any patient with end-stage lung disease could receive an ex vivo bioengineered lung generated from autologous iPS cells obtained from a simple skin biopsy. Successful completion of this project would also result in the first three-dimensional model system able to examine human lung epithelial lineage relationships and able to functionally test putative human lung stem/progenitor populations both in vitro and in vivo. For this proposal we have assembled four teams with expertise in stem cell and developmental biology, tissue engineering, biomedical engineering, veterinary medicine, and lung cell biology. We propose to utilize iPS cells we have derived from humans with/without cystic fibrosis to develop methods for: a) directed differentiation of the iPS cells into lung epithelial progenitors and endothelial cells, b) ex vivo seeding of the resulting cells onto pulmonary airway, alveolar, and vascular compartments of decellularized human lung scaffolds, c) transplantation of the bioengineered lungs into large animal recipients, and d) development of an ex vivo 3D bioartificial lung model of inherited lung disease.

Public Health Relevance

End stage lung diseases, such as cystic fibrosis and emphysema, are responsible for considerable morbidity and mortality. This transformative project proposes to develop the methodologies necessary to derive an entire functioning transplantable humanized lung from induced pluripotent stem (iPS) cells generated from skin biopsies of humans with cystic fibrosis. For pre-clinical testing the bioengineered humanized lungs, made by seeding the cells onto lung scaffolds, will be studied after transplantation into animals.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-N (M1))
Program Officer
Blaisdell, Carol J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Boston University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Hawkins, Finn; Kramer, Philipp; Jacob, Anjali et al. (2017) Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells. J Clin Invest 127:2277-2294
Serra, Maria; Alysandratos, Konstantinos-Dionysios; Hawkins, Finn et al. (2017) Pluripotent stem cell differentiation reveals distinct developmental pathways regulating lung- versus thyroid-lineage specification. Development 144:3879-3893
Gilpin, Sarah E; Charest, Jonathan M; Ren, Xi et al. (2016) Regenerative potential of human airway stem cells in lung epithelial engineering. Biomaterials 108:111-9
Kurmann, Anita A; Serra, Maria; Hawkins, Finn et al. (2015) Regeneration of Thyroid Function by Transplantation of Differentiated Pluripotent Stem Cells. Cell Stem Cell 17:527-42
Wilson, Andrew A; Ying, Lei; Liesa, Marc et al. (2015) Emergence of a stage-dependent human liver disease signature with directed differentiation of alpha-1 antitrypsin-deficient iPS cells. Stem Cell Reports 4:873-85
Gilpin, Sarah E; Ren, Xi; Okamoto, Tatsuya et al. (2014) Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix. Ann Thorac Surg 98:1721-9; discussion 1729
Guyette, Jacques P; Gilpin, Sarah E; Charest, Jonathan M et al. (2014) Perfusion decellularization of whole organs. Nat Protoc 9:1451-68
Longmire, Tyler A; Ikonomou, Laertis; Hawkins, Finn et al. (2012) Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell 10:398-411
Longmire, Tyler A; Ikonomou, Laertis; Kotton, Darrell N (2012) Mouse ESC Differentiation to Nkx2.1+ Lung and Thyroid Progenitors. Bio Protoc 2: